TN-201
TN-201-0009
Phase 2 gene_therapy active
Quick answer
TN-201 for Hypertrophic Cardiomyopathy is a Phase 2 program (gene_therapy) at Tenaya Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tenaya Therapeutics
- Indication
- Hypertrophic Cardiomyopathy
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active